GlassScriptPhysician profile
Deepak Venkat Sree
NPI 1235391988
$16,505.18
in general payments reported to CMS, 2019-2025
39 companies · $1,998 in 2025
The $1,998 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,427 · 2020: $1,680 · 2021: $2,584 · 2022: $2,694 · 2023: $2,747 · 2024: $2,375 · 2025: $1,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,102 · Education: $18.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,102.10 |
| Education | $18.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,510.17 | 2019-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $2,373.77 | 2019-2025 | Evenity, Prolia, Enbrel |
| Ucb, INC. | $1,352.04 | 2019-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $1,094.09 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,047.67 | 2019-2025 | Orencia |
| Janssen Biotech, INC. | $941.26 | 2019-2025 | Tremfya, Simponi Aria |
| Glaxosmithkline, LLC. | $872.87 | 2019-2025 | Benlysta |
| Pfizer INC. | $465.50 | 2019-2025 | |
| Radius Health, INC. | $381.82 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.29 | 2019-2024 | Ofev, Cyltezo |
| Aurinia Pharma U.S., INC. | $310.12 | 2021-2024 | Lupkynis |
| Genentech USA, INC. | $303.05 | 2019-2025 | Gazyva, Actemra |
| Astrazeneca Pharmaceuticals LP | $282.63 | 2021-2025 | Saphnelo |
| Horizon Therapeutics Plc | $276.13 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $270.35 | 2019 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Sree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.